Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Cash from Financing Activities (2009 - 2026)

Updated

Vistagen Therapeutics (VTGN) reported Cash from Financing Activities of $351,000 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 98.7% from $27.65 million a year earlier and down 61.4% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Vistagen Therapeutics' Cash from Financing Activities came in at $3.09 million, down 90.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $30.97 million, up 864.8% from FY2025.

  • Cash from Financing Activities has a five-year compound annual growth rate of -23.0% (FY2021 to FY2026).
  • By fiscal year, Cash from Financing Activities came in at $3.21 million in FY2025 (-97.5%), $128.4 million in FY2024, -$1.04 million in FY2023 and $10.48 million in FY2022 (-90.8%).
  • Five-year quarterly Cash from Financing Activities spans a low of -$397,400 in fiscal Q4 2023 and a high of $93.73 million in fiscal Q3 2024.
  • Year over year, Cash from Financing Activities gained in 1 of the last four quarters, with an average decline of 39.0%.
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $909,000 (Q1 2027), -$283,000 (Q4 2026) and $2.11 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 855,000.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -7.22 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -8.53 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 6.82 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -2.43 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -1.53 Bn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 351,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 351,000.00
Jun 30, 2026 909,000.00
Mar 31, 2026 -283,000.00
Dec 31, 2025 2.11 Mn
Sep 30, 2025 27.65 Mn
Jun 30, 2025 1.49 Mn
Mar 31, 2025 1.95 Mn
Dec 31, 2024 1.17 Mn
Jun 30, 2024 88,000.00
Mar 31, 2024 -380,000.00
Dec 31, 2023 93.73 Mn
Sep 30, 2023 34.18 Mn
Jun 30, 2023 875,000.00
Mar 31, 2023 -397,400.00
Dec 31, 2022 -304,100.00
Sep 30, 2022 -334,000.00
Jun 30, 2022 -5,500.00
Mar 31, 2022 23,700.00
Dec 31, 2021 2.12 Mn
Sep 30, 2021 7.35 Mn
API Access

Vistagen Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=VTGN&period=max&api_key=YOUR_API_KEY